I. Important Notes
This semi-annual report summary is derived from the full semi-annual report. Investors should read the full report on the media designated by the China Securities Regulatory Commission to fully understand the company's operating results, financial position, and future development plans. All directors attended the board meeting to review this report.
Profit distribution plan or capital reserve conversion plan for the reporting period: Applicable.
The company's profit distribution plan approved by the board is: Based on 232,971,251 shares, a cash dividend of 1 RMB (tax included) will be distributed for every 10 shares to all shareholders. No bonus shares will be issued, and no capital reserve will be converted into share capital.
II. Company Profile
1. Company Introduction
| Item | Details |
|---|---|
| Stock Abbreviation | PharmaBlock |
| Stock Code | 300725 |
| Stock Exchange | Shenzhen Stock Exchange |